Literature DB >> 7563342

Transition zone index as a method of assessing benign prostatic hyperplasia: correlation with symptoms, urine flow and detrusor pressure.

S A Kaplan1, A E Te, L B Pressler, C A Olsson.   

Abstract

PURPOSE: Prostate volume has been poorly correlated to various parameters used to assess benign prostatic hyperplasia (BPH), including symptoms, peak urine flow and detrusor pressure at peak urine flow. The purpose of this study was 2-fold: 1) to determine if transrectal ultrasound measurement of the transition zone of the prostate served as a better proxy for determining prostate size and correlated better with American Urological Association symptom score, peak urine flow and detrusor pressure, and 2) if the parameter transition zone index (the ratio between transition zone volume and prostate volume) was useful in evaluating clinical prostatism.
MATERIALS AND METHODS: We prospectively evaluated 61 men with symptomatic BPH (age 64.6 +/- 9.7 years) according to symptoms, peak urine flow, pressure/flow analysis, transrectal ultrasound volume of the entire prostate and the transition zone, and calculation of the transition zone index.
RESULTS: Age correlated with symptoms (r = 0.31, p = 0.01) and peak urine flow correlated negatively with symptoms and age (p = 0.002). Age also correlated with prostate volume (r = 0.54 and p = 0.03) and transition zone (r = 0.31, p = 0.05). There was a weak correlation between prostate volume and symptoms, peak urine flow and detrusor pressure at peak urine flow; a stronger correlation between transition zone and symptoms (r = 0.48, p = 0.03), and peak urine flow (r = -0.34, p = 0.05), and a significant correlation (p = 0.001) between transition zone index and symptoms (r = 0.75), peak urine flow (r = -0.71) and detrusor pressure at peak urine flow (r = 0.43). A transition zone index of greater than 0.50 was a useful cutoff point and highly significant (p = 0.002) for delineating patients with more severe abnormalities of symptoms, peak urine flow and detrusor pressure at peak urine flow.
CONCLUSIONS: Transition zone index is a parameter that correlates significantly with evaluated parameters of BPH and may serve as a useful proxy for evaluating worsening obstruction. Studies are underway to determine if transition zone index can be used prospectively to predict and correlate response with therapies designed to ablate prostatic tissue medically or surgically.

Entities:  

Mesh:

Year:  1995        PMID: 7563342

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  30 in total

Review 1.  The use of baseline clinical measures to predict those at risk for progression of benign prostatic hyperplasia.

Authors:  Edward D Kim
Journal:  Curr Urol Rep       Date:  2004-08       Impact factor: 3.092

2.  Prostatic peripheral zone thickness: what is normal on magnetic resonance imaging?

Authors:  Neil F Wasserman; Benjamin Spilseth; Tina Sanghvi
Journal:  Abdom Radiol (NY)       Date:  2020-07-27

3.  Correlation between the total volume, transitional zone volume of the prostate, transitional prostate zone index and lower urinary tract symptoms (LUTS).

Authors:  Mario Franciosi; Walter José Koff; Ernani Luis Rhoden
Journal:  Int Urol Nephrol       Date:  2007-01-04       Impact factor: 2.370

4.  Age-related changes in prostate zonal volumes as measured by high-resolution magnetic resonance imaging (MRI): a cross-sectional study in over 500 patients.

Authors:  Baris Turkbey; Robert Huang; Srinivas Vourganti; Hari Trivedi; Marcelino Bernardo; Pingkun Yan; Compton Benjamin; Peter A Pinto; Peter L Choyke
Journal:  BJU Int       Date:  2012-09-14       Impact factor: 5.588

5.  Correlation of Prostate Gland Size and Uroflowmetry in Patients with Lower Urinary Tract Symptoms.

Authors:  Deepak Sundaram; Ponnusamy Kasirajan Sankaran; Gunapriya Raghunath; S Vijayalakshmi; J Vijayakumar; Maria Francis Yuvaraj; Munnusamy Kumaresan; Zareena Begum
Journal:  J Clin Diagn Res       Date:  2017-05-01

Review 6.  Benign Prostatic Hyperplasia and Lower Urinary Tract Symptoms: What Is the Role and Significance of Inflammation?

Authors:  Granville L Lloyd; Jeffrey M Marks; William A Ricke
Journal:  Curr Urol Rep       Date:  2019-08-03       Impact factor: 3.092

7.  Vascular damage induced by type 2 diabetes mellitus as a risk factor for benign prostatic hyperplasia.

Authors:  A P Berger; M Deibl; E J Halpern; M Lechleitner; J Bektic; W Horninger; G Fritsche; H Steiner; A Pelzer; G Bartsch; F Frauscher
Journal:  Diabetologia       Date:  2005-03-09       Impact factor: 10.122

Review 8.  Early treatment of benign prostatic hyperplasia: implications for reducing the risk of permanent bladder damage.

Authors:  Andrea Tubaro; Simon Carter; Alberto Trucchi; Giorgio Punzo; Stefano Petta; Lucio Miano
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

9.  Androgen receptor and immune inflammation in benign prostatic hyperplasia and prostate cancer.

Authors:  Kouji Izumi; Lei Li; Chawnshang Chang
Journal:  Clin Investig (Lond)       Date:  2014-10-01

10.  Stromal growth and epithelial cell proliferation in ventral prostates of liver X receptor knockout mice.

Authors:  Hyun-Jin Kim; Leif C Andersson; Didier Bouton; Margaret Warner; Jan-Ake Gustafsson
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-02       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.